Easywell Biomedicals, Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was TWD 35.07 million compared to TWD 71.64 million a year ago. Net loss was TWD 52.18 million compared to net income of TWD 5.06 million a year ago. Basic loss per share from continuing operations was TWD 0.32 compared to basic earnings per share from continuing operations of TWD 0.04 a year ago. Basic loss per share was TWD 0.32 compared to basic earnings per share of TWD 0.04 a year ago.